Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Oncogenes in human leukemia].

F Takaku1

  • 1Third Dept. of Medicine, Faculty of Medicine, University of Tokyo.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|March 1, 1989
PubMed
Summary
This summary is machine-generated.

This study identifies ras oncogene point mutations in human leukemia and myelodysplastic syndrome. Detecting these mutations aids in early diagnosis, remission assessment, and relapse detection for better patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Serum erythropoietin titers in hematological malignancies and related diseases.

International journal of cell cloning·1992
Same author

Increased respiratory burst activity of neutrophils in patients with aplastic anemia: effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor.

Experimental hematology·1992
Same author

Production of interleukin 3 and granulocyte-macrophage colony-stimulating factor from stimulated blood mononuclear cells in patients with aplastic anemia.

Experimental hematology·1992
Same author

Correlation of antibodies to ribosomal P protein with psychosis in patients with systemic lupus erythematosus.

Annals of the rheumatic diseases·1992
Same author

Changes of enzyme activity levels in red blood cells in hemodialysis patients by recombinant human erythropoietin.

Nihon Jinzo Gakkai shi·1992
Same author

[Present status and future aspects of clinical use of cytokines].

Nihon rinsho. Japanese journal of clinical medicine·1992
Same journal

[A Case of Pulmonary Epithelioid Hemangioendothelioma Associated with Multiple Cancers].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Long-Term Survival in Three Cases with Pulmonary Metastases from Colorectal Cancer Given Low-Dose S-1 Under a Regimen Combining a Carbohydrate-Restricted Ketogenic Diet, Metformin, Vitamin D, Eicosapentaenoic Acid, and Other Complementary Therapies].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Preventive Effect of Saline Eye Wash for Eye Symptoms Due to High-Dose and Intermediate-Dose Cytarabine Therapy].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Examination of Factors Affecting the Efficacy of Naldemedine Tosilate Tablets for Opioid-Induced Constipation].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Recent Advances in the Treatment of HER2-Altered Solid Tumors].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[BRAF-Mutant Solid Tumor].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
See all related articles

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Context:

  • Ras oncogene activation is implicated in human leukemias and myelodysplastic syndromes.
  • Point mutations in codons 12, 13, and 61 of ras genes are frequently observed in these hematological malignancies.

Purpose:

  • To develop and validate a sensitive method for detecting ras oncogene point mutations in patient-derived DNA.
  • To assess the utility of these mutations as diagnostic and prognostic markers in leukemia and myelodysplastic syndrome.

Summary:

  • Oligonucleotide probes targeting mutated codons (12, 13, 61) were used with dot blot analysis.
  • Polymerase chain reaction (PCR) amplification enhanced the sensitivity for detecting ras gene point mutations.
  • The study also briefly mentions the diagnostic utility of bcr-abl fusion gene analysis in chronic myelogenous leukemia and Ph1-positive acute lymphoblastic leukemia.

Related Experiment Videos

Impact:

  • Early and accurate detection of ras mutations can significantly improve leukemia and myelodysplastic syndrome diagnosis.
  • Monitoring these mutations aids in determining remission status and enables early identification of relapse.
  • This molecular approach offers a valuable tool for personalized cancer management and treatment strategies.